Filing metadata

Accession number
0000929638-23-001211
Form type
Form 4
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Apr 20, 2023
Reporting period
Apr 18, 2023
Description
Insider transaction

Explore SEC Filings Hub